Search Contract Opportunities

Notice of Intent to Sole Source Biolytic Lab Performance Dr. Oligo 48 Synthesizer Maintenance

ID: 82582 • Type: Special Notice

Description

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Biolytic Lab Performance INC, for equipment maintenance of two of the Biolytic : Dr Oligo 48 Medium Throughput DNA Synthesizers SN: BLP-D48-0132 / SN: BLP-D48-0127. This service maintains the operational readiness of a critical laboratory instrument. The instrument participates in standard laboratory operations as well as public health emergencies and requires regular maintenance and parts for consistent operation. Biolytic is the manufacturer of this Biolytic-Dr Oligo-48 DNA synthesizer and has the knowledge and experience to service regular maintenance. They also have a 24 - 48hour response time and one preventive maintenance visit is included with the service contract; and service engineers who have experience with these DNA synthesizers.

-Service engineers have Dr Oligo48 instrument repair training

-Minimum of 10 years field service experience on instruments

-Use Genuine OEM parts.

This is the only contractor that has been identified, who has trained service engineers with a proven track record on maintaining and repairing the Biolytic Dr Oligo-48 Synthesizer, and therefore, has the capability to respond to our service requirements. Biolytic is the only responsible source and no other vendor can provide the above -mentioned services needed to satisfy the program requirement. Since the instrument is used on a daily basis, it is imperative that our system is kept up and running with as little down time as possible.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at qsx8@cdc.gov by COB 5pm, February 2, 2024.

Background
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Biolytic Lab Performance INC for equipment maintenance of two Biolytic Dr Oligo 48 Medium Throughput DNA Synthesizers. The service is essential for maintaining the operational readiness of a critical laboratory instrument that participates in standard laboratory operations as well as public health emergencies. Biolytic is the manufacturer of this equipment and has the knowledge, experience, and trained service engineers to provide regular maintenance. The contract action is being pursued under the authority of 10 U.S.C. 2304(c)(1).

Work Details
The contractor will provide a Service Contract for equipment maintenance of the two Biolytic Dr Oligo 48 Medium Throughput DNA Synthesizers, including all labor, travel, parts with unlimited breakdown calls included, and one scheduled Preventative Maintenance visit per year. Additionally, priority response for all breakdown calls is required. The purpose of this procurement is to ensure that the instruments are under maintenance agreements to comply with the requirements of the Quality Management System (QMS) and to provide synthesis of oligonucleotides for CDC researchers.

Period of Performance
The period of performance for this contract is from 02/10/2024 to 02/09/2026.

Overview

Response Deadline
Feb. 2, 2024, 5:00 p.m. EST Past Due
Posted
Jan. 18, 2024, 2:01 p.m. EST
Set Aside
None
Place of Performance
Atlanta, GA 30341 United States
Source
SAM

Current SBA Size Standard
$34 Million
Pricing
Fixed Price
Evaluation Criteria
Lowest Price Technically Acceptable (LPTA)
Est. Level of Competition
Sole Source
On 1/18/24 Centers for Disease Control and Prevention issued Special Notice 82582 for Notice of Intent to Sole Source Biolytic Lab Performance Dr. Oligo 48 Synthesizer Maintenance due 2/2/24.
Primary Contact
Name
Iris Gonzalez   Profile
Email
Phone
None

Documents

Posted documents for Special Notice 82582

Question & Answer

Contract Awards

Prime contracts awarded through Special Notice 82582

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice 82582

Similar Active Opportunities

Open contract opportunities similar to Special Notice 82582

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > CENTERS FOR DISEASE CONTROL AND PREVENTION > CDC OFFICE OF ACQUISITION SERVICES
FPDS Organization Code
7523-00254
Source Organization Code
100188028
Last Updated
Feb. 2, 2024
Last Updated By
qsx8@cdc.gov
Archive Date
Feb. 2, 2024